| UniProt ID | KCAB2_HUMAN | |
|---|---|---|
| UniProt AC | Q13303 | |
| Protein Name | Voltage-gated potassium channel subunit beta-2 | |
| Gene Name | KCNAB2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 367 | |
| Subcellular Localization |
Cytoplasm . Membrane Peripheral membrane protein Cytoplasmic side . Cell membrane Peripheral membrane protein Cytoplasmic side . Cell projection, axon . Cell junction, synapse, synaptosome . Cytoplasm, cytoskeleton . Recruited to the cytoplas |
|
| Protein Description | Cytoplasmic potassium channel subunit that modulates the characteristics of the channel-forming alpha-subunits. [PubMed: 7649300] | |
| Protein Sequence | MYPESTTGSPARLSLRQTGSPGMIYSTRYGSPKRQLQFYRNLGKSGLRVSCLGLGTWVTFGGQITDEMAEQLMTLAYDNGINLFDTAEVYAAGKAEVVLGNIIKKKGWRRSSLVITTKIFWGGKAETERGLSRKHIIEGLKASLERLQLEYVDVVFANRPDPNTPMEETVRAMTHVINQGMAMYWGTSRWSSMEIMEAYSVARQFNLTPPICEQAEYHMFQREKVEVQLPELFHKIGVGAMTWSPLACGIVSGKYDSGIPPYSRASLKGYQWLKDKILSEEGRRQQAKLKELQAIAERLGCTLPQLAIAWCLRNEGVSSVLLGASNADQLMENIGAIQVLPKLSSSIIHEIDSILGNKPYSKKDYRS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MYPESTTGS ------CCCCCCCCC | 18.73 | 26552605 | |
| 3 (in isoform 3) | Phosphorylation | - | 27.97 | 23663014 | |
| 5 | Phosphorylation | ---MYPESTTGSPAR ---CCCCCCCCCCCE | 27.11 | 22115753 | |
| 5 (in isoform 3) | Phosphorylation | - | 27.11 | 23663014 | |
| 6 (in isoform 3) | Phosphorylation | - | 33.25 | 23663014 | |
| 6 | Phosphorylation | --MYPESTTGSPARL --CCCCCCCCCCCEE | 33.25 | 22115753 | |
| 7 (in isoform 3) | Phosphorylation | - | 44.96 | 23663014 | |
| 7 | Phosphorylation | -MYPESTTGSPARLS -CCCCCCCCCCCEEE | 44.96 | 23401153 | |
| 9 (in isoform 3) | Phosphorylation | - | 17.19 | 23663014 | |
| 9 | Phosphorylation | YPESTTGSPARLSLR CCCCCCCCCCEEEEE | 17.19 | 23401153 | |
| 12 | Methylation | STTGSPARLSLRQTG CCCCCCCEEEEECCC | 28.35 | 115386339 | |
| 12 (in isoform 3) | Phosphorylation | - | 28.35 | 23663014 | |
| 14 | Phosphorylation | TGSPARLSLRQTGSP CCCCCEEEEECCCCC | 18.89 | 25159151 | |
| 14 (in isoform 3) | Phosphorylation | - | 18.89 | 23663014 | |
| 14 (in isoform 2) | Phosphorylation | - | 18.89 | 24719451 | |
| 14 | O-linked_Glycosylation | TGSPARLSLRQTGSP CCCCCEEEEECCCCC | 18.89 | 31492838 | |
| 15 (in isoform 3) | Phosphorylation | - | 5.79 | 23663014 | |
| 18 (in isoform 2) | Phosphorylation | - | 32.94 | - | |
| 18 | Phosphorylation | ARLSLRQTGSPGMIY CEEEEECCCCCCCEE | 32.94 | 23401153 | |
| 20 (in isoform 2) | Phosphorylation | - | 22.97 | 25159151 | |
| 20 | Phosphorylation | LSLRQTGSPGMIYST EEEECCCCCCCEEEC | 22.97 | 21945579 | |
| 25 (in isoform 2) | Phosphorylation | - | 8.63 | - | |
| 25 | Phosphorylation | TGSPGMIYSTRYGSP CCCCCCEEECCCCCH | 8.63 | 21945579 | |
| 26 | Phosphorylation | GSPGMIYSTRYGSPK CCCCCEEECCCCCHH | 8.76 | 21945579 | |
| 26 | O-linked_Glycosylation | GSPGMIYSTRYGSPK CCCCCEEECCCCCHH | 8.76 | 31492838 | |
| 27 | Phosphorylation | SPGMIYSTRYGSPKR CCCCEEECCCCCHHH | 15.78 | 21945579 | |
| 28 | Methylation | PGMIYSTRYGSPKRQ CCCEEECCCCCHHHH | 28.07 | 24129315 | |
| 28 | Asymmetric dimethylarginine | PGMIYSTRYGSPKRQ CCCEEECCCCCHHHH | 28.07 | - | |
| 29 | Phosphorylation | GMIYSTRYGSPKRQL CCEEECCCCCHHHHH | 23.26 | 24043423 | |
| 31 | Phosphorylation | IYSTRYGSPKRQLQF EEECCCCCHHHHHHH | 20.50 | 24043423 | |
| 44 | Ubiquitination | QFYRNLGKSGLRVSC HHHHHHCCCCCEEEE | 44.51 | - | |
| 51 (in isoform 3) | Phosphorylation | - | 2.98 | 24719451 | |
| 57 | Ubiquitination | SCLGLGTWVTFGGQI EEEECCCEEEECCEE | 5.83 | 19608861 | |
| 57 | Acetylation | SCLGLGTWVTFGGQI EEEECCCEEEECCEE | 5.83 | 19608861 | |
| 111 | Phosphorylation | KKKGWRRSSLVITTK HHCCCCCCCEEEEEE | 21.32 | 26657352 | |
| 112 | Phosphorylation | KKGWRRSSLVITTKI HCCCCCCCEEEEEEE | 25.50 | 23401153 | |
| 116 | Phosphorylation | RRSSLVITTKIFWGG CCCCEEEEEEEECCC | 17.98 | 23882029 | |
| 117 | Phosphorylation | RSSLVITTKIFWGGK CCCEEEEEEEECCCC | 15.83 | 23882029 | |
| 124 | Acetylation | TKIFWGGKAETERGL EEEECCCCHHCCCCC | 38.83 | 19608861 | |
| 124 | Ubiquitination | TKIFWGGKAETERGL EEEECCCCHHCCCCC | 38.83 | 19608861 | |
| 134 | Ubiquitination | TERGLSRKHIIEGLK CCCCCCHHHHHHHHH | 35.46 | - | |
| 138 (in isoform 3) | Ubiquitination | - | 58.85 | - | |
| 157 (in isoform 3) | Ubiquitination | - | 10.26 | - | |
| 157 | Acetylation | EYVDVVFANRPDPNT EEEEEEEECCCCCCC | 10.26 | 19608861 | |
| 167 (in isoform 3) | Ubiquitination | - | 52.28 | - | |
| 184 | Phosphorylation | INQGMAMYWGTSRWS HHHHCHHHCCCCCCC | 7.37 | - | |
| 205 (in isoform 3) | Phosphorylation | - | 7.24 | - | |
| 206 (in isoform 3) | Phosphorylation | - | 34.37 | - | |
| 207 | Acetylation | SVARQFNLTPPICEQ HHHHHCCCCHHHHHH | 8.86 | 19608861 | |
| 208 | Phosphorylation | VARQFNLTPPICEQA HHHHCCCCHHHHHHH | 28.29 | 24043423 | |
| 217 | Phosphorylation | PICEQAEYHMFQREK HHHHHHHHHHHHHHC | 11.12 | 24043423 | |
| 224 | Acetylation | YHMFQREKVEVQLPE HHHHHHHCEEEEHHH | 45.98 | 25953088 | |
| 224 | Ubiquitination | YHMFQREKVEVQLPE HHHHHHHCEEEEHHH | 45.98 | - | |
| 235 | Ubiquitination | QLPELFHKIGVGAMT EHHHHHHHHCCCCCC | 33.55 | - | |
| 254 (in isoform 2) | Ubiquitination | - | 38.08 | 21890473 | |
| 254 | Ubiquitination | ACGIVSGKYDSGIPP CCCCCCCCCCCCCCC | 38.08 | 21890473 | |
| 266 | Phosphorylation | IPPYSRASLKGYQWL CCCCCHHHHCCHHHH | 29.51 | - | |
| 268 (in isoform 1) | Ubiquitination | - | 53.75 | 21890473 | |
| 268 | Acetylation | PYSRASLKGYQWLKD CCCHHHHCCHHHHHH | 53.75 | 25953088 | |
| 268 | Ubiquitination | PYSRASLKGYQWLKD CCCHHHHCCHHHHHH | 53.75 | 21890473 | |
| 268 | Ubiquitination | PYSRASLKGYQWLKD CCCHHHHCCHHHHHH | 53.75 | 21890473 | |
| 272 (in isoform 3) | Ubiquitination | - | 9.26 | - | |
| 274 | Acetylation | LKGYQWLKDKILSEE HCCHHHHHHHHCCHH | 54.75 | 19608861 | |
| 274 | Ubiquitination | LKGYQWLKDKILSEE HCCHHHHHHHHCCHH | 54.75 | 19608861 | |
| 276 | Acetylation | GYQWLKDKILSEEGR CHHHHHHHHCCHHHH | 43.91 | 23749302 | |
| 276 | Ubiquitination | GYQWLKDKILSEEGR CHHHHHHHHCCHHHH | 43.91 | 21890473 | |
| 276 (in isoform 2) | Ubiquitination | - | 43.91 | 21890473 | |
| 276 | Ubiquitination | GYQWLKDKILSEEGR CHHHHHHHHCCHHHH | 43.91 | - | |
| 290 | Ubiquitination | RRQQAKLKELQAIAE HHHHHHHHHHHHHHH | 56.52 | 2189047 | |
| 290 | Ubiquitination | RRQQAKLKELQAIAE HHHHHHHHHHHHHHH | 56.52 | 21890473 | |
| 290 (in isoform 1) | Ubiquitination | - | 56.52 | 21890473 | |
| 295 | Acetylation | KLKELQAIAERLGCT HHHHHHHHHHHHCCC | 2.36 | 19608861 | |
| 316 (in isoform 3) | Ubiquitination | - | 28.31 | - | |
| 316 | Ubiquitination | AWCLRNEGVSSVLLG HHHHHCCCCCHHECC | 28.31 | 21890473 | |
| 322 (in isoform 3) | Ubiquitination | - | 5.16 | - | |
| 322 | Acetylation | EGVSSVLLGASNADQ CCCCHHECCCCCHHH | 5.16 | 19608861 | |
| 324 (in isoform 3) | Ubiquitination | - | 10.28 | - | |
| 338 | Ubiquitination | MENIGAIQVLPKLSS HHHHCHHHHHHHCCH | 30.11 | 21890473 | |
| 338 (in isoform 3) | Ubiquitination | - | 30.11 | - | |
| 358 | Acetylation | IDSILGNKPYSKKDY HHHHHCCCCCCCHHC | 43.46 | 25953088 | |
| 358 | Ubiquitination | IDSILGNKPYSKKDY HHHHHCCCCCCCHHC | 43.46 | - | |
| 360 | Phosphorylation | SILGNKPYSKKDYRS HHHCCCCCCCHHCCC | 34.43 | 19060867 | |
| 362 | Ubiquitination | LGNKPYSKKDYRS-- HCCCCCCCHHCCC-- | 43.77 | 19608861 | |
| 362 | Acetylation | LGNKPYSKKDYRS-- HCCCCCCCHHCCC-- | 43.77 | 19608861 | |
| 363 | Ubiquitination | GNKPYSKKDYRS--- CCCCCCCHHCCC--- | 54.79 | - | |
| 406 (in isoform 3) | Ubiquitination | - | - | ||
| 410 | Acetylation | -------------------------------------------------- -------------------------------------------------- | 19608861 | ||
| 410 (in isoform 3) | Ubiquitination | - | - | ||
| 411 (in isoform 3) | Ubiquitination | - | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCAB2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCAB2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KCNA5_HUMAN | KCNA5 | physical | 23390957 | |
| KCNA4_HUMAN | KCNA4 | physical | 23390957 | |
| SIR1_HUMAN | SIRT1 | physical | 23390957 | |
| KCAB2_HUMAN | KCNAB2 | physical | 25416956 | |
| KCAB1_HUMAN | KCNAB1 | physical | 26186194 | |
| GAPD1_HUMAN | GAPVD1 | physical | 26186194 | |
| PUR9_HUMAN | ATIC | physical | 26344197 | |
| NTF2_HUMAN | NUTF2 | physical | 26344197 | |
| TNNC2_HUMAN | TNNC2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-124, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-25, AND MASSSPECTROMETRY. | |